Background: “Hospital at Home” (HaH) models of care have existed for over 20 years in the U.S. Recent demand for healthcare value, advances in relevant technologies, and the ongoing global pandemic have driven renewed attention to HaH models, including from the Center for Medicare and Medicaid Services (CMS), and have spawned several pilots within the [...]

Background: The ongoing global COVID-19 pandemic has stressed patients, hospital systems, and society and, while treatment modalities are continuously evolving. A phase 3 clinical trial of monoclonal antibody infusion in appropriate patients with Casirivimab and Imbdevimab demonstrated a 70% reduction in hospitalization or all-cause death compared to placebo (ref 1). An emergency use authorization by [...]